GT200500282A - Heteroatomos conteniendo compuestos triciclicos. - Google Patents
Heteroatomos conteniendo compuestos triciclicos.Info
- Publication number
- GT200500282A GT200500282A GT200500282A GT200500282A GT200500282A GT 200500282 A GT200500282 A GT 200500282A GT 200500282 A GT200500282 A GT 200500282A GT 200500282 A GT200500282 A GT 200500282A GT 200500282 A GT200500282 A GT 200500282A
- Authority
- GT
- Guatemala
- Prior art keywords
- heteroatomos
- tricycle
- compounds
- tricycle compounds
- epicloro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A COMPUESTOS TRICÍCLICOS QUE CONTIENEN ÁTOMOS HETEROGÉNEOS, POR EJEMPLO A UN PROCEDICMIENTO PARA LA PRODUCCIÓN DE 33-EPICLORO-33-DESOXIASCOMICINA O 33-EPI-33-CLORO-FR 520, EL MISMO PUEDE SER UTILIZADO PARA EL TRATAMIENTO DE ENFERMEDADES INMUNES, ALERGICAS, DE LA PIEL COM POR EJEMPLO PSORIASIS, DERMATITIS ATOPICA, ENTRE OTRAS.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0422643A GB0422643D0 (en) | 2004-10-12 | 2004-10-12 | Organic compounds |
| GB0427599A GB0427599D0 (en) | 2004-12-16 | 2004-12-16 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT200500282A true GT200500282A (es) | 2006-05-04 |
Family
ID=36084355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT200500282A GT200500282A (es) | 2004-10-12 | 2005-10-07 | Heteroatomos conteniendo compuestos triciclicos. |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7514554B2 (es) |
| EP (1) | EP1802635B8 (es) |
| JP (1) | JP5032326B2 (es) |
| KR (1) | KR101228188B1 (es) |
| CN (1) | CN101031573B (es) |
| AR (1) | AR051386A1 (es) |
| AU (1) | AU2005293799B2 (es) |
| BR (1) | BRPI0516873A (es) |
| CA (1) | CA2581046C (es) |
| DK (1) | DK1802635T3 (es) |
| EC (1) | ECSP077384A (es) |
| ES (1) | ES2389206T3 (es) |
| GT (1) | GT200500282A (es) |
| HK (1) | HK1105634A1 (es) |
| IL (1) | IL182307A (es) |
| JO (1) | JO2727B1 (es) |
| MA (1) | MA28932B1 (es) |
| MX (1) | MX2007004258A (es) |
| MY (1) | MY140880A (es) |
| NO (1) | NO338603B1 (es) |
| NZ (1) | NZ554010A (es) |
| PE (1) | PE20060581A1 (es) |
| PL (1) | PL1802635T3 (es) |
| PT (1) | PT1802635E (es) |
| RU (1) | RU2394037C2 (es) |
| TN (1) | TNSN07133A1 (es) |
| TW (1) | TWI361192B (es) |
| WO (1) | WO2006040111A2 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200628483A (en) * | 2004-12-01 | 2006-08-16 | Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag | Processes for producing crystalline macrolides |
| IT1394309B1 (it) | 2009-05-22 | 2012-06-06 | Poli Ind Chimica Spa | Nuovo approccio chimico-enzimatico alla sintesi del pimecrolimus |
| EP3178824A1 (en) | 2015-12-08 | 2017-06-14 | Medichem, S.A. | Process for preparing pimecrolimus |
| CN106854228B (zh) * | 2015-12-08 | 2020-05-29 | 博瑞生物医药（苏州）股份有限公司 | 一种吡美莫司的制备方法 |
| WO2018202733A1 (en) | 2017-05-01 | 2018-11-08 | Meda Pharma Gmbh & Co. Kg | Process to convert crude ascomycin into purified pimecrolimus |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4464366A (en) * | 1979-12-19 | 1984-08-07 | Ciba Geigy Corporation | Cephem compounds having a terminal aminocarboxylic acid grouping and containing an azacyclyl(thio)ureido group |
| US4894366A (en) * | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| US5352671A (en) * | 1989-11-09 | 1994-10-04 | Sandoz Ltd. | Heteroatoms-containing tricyclic compounds |
| NZ235991A (en) * | 1989-11-09 | 1993-05-26 | Sandoz Ltd | Macrolide compounds and pharmaceutical compositions thereof |
| EP0480623A1 (en) | 1990-10-11 | 1992-04-15 | Merck & Co. Inc. | New halomacrolides and derivatives having immunosuppressive activity |
| MY110603A (en) | 1993-05-27 | 1998-08-29 | Novartis Ag | Tetrahydropyran derivatives |
| US6160117A (en) * | 1997-11-06 | 2000-12-12 | Zeneca Limited | Chemical process |
| GB0012383D0 (en) * | 2000-05-22 | 2000-07-12 | Novartis Ag | Organic compounds |
| US6667312B2 (en) * | 2000-12-08 | 2003-12-23 | 3M Innovative Properties Company | Thioether substituted imidazoquinolines |
-
2005
- 2005-10-07 GT GT200500282A patent/GT200500282A/es unknown
- 2005-10-09 JO JO2005138A patent/JO2727B1/en active
- 2005-10-10 NZ NZ554010A patent/NZ554010A/en unknown
- 2005-10-10 AU AU2005293799A patent/AU2005293799B2/en active Active
- 2005-10-10 CN CN2005800333070A patent/CN101031573B/zh active Active
- 2005-10-10 MX MX2007004258A patent/MX2007004258A/es active IP Right Grant
- 2005-10-10 KR KR1020077008216A patent/KR101228188B1/ko active IP Right Grant
- 2005-10-10 WO PCT/EP2005/010889 patent/WO2006040111A2/en active Application Filing
- 2005-10-10 DK DK05793907.6T patent/DK1802635T3/da active
- 2005-10-10 CA CA2581046A patent/CA2581046C/en active Active
- 2005-10-10 PT PT05793907T patent/PT1802635E/pt unknown
- 2005-10-10 PL PL05793907T patent/PL1802635T3/pl unknown
- 2005-10-10 RU RU2007117497/04A patent/RU2394037C2/ru active
- 2005-10-10 US US11/575,757 patent/US7514554B2/en active Active
- 2005-10-10 JP JP2007536064A patent/JP5032326B2/ja active Active
- 2005-10-10 ES ES05793907T patent/ES2389206T3/es active Active
- 2005-10-10 EP EP05793907.6A patent/EP1802635B8/en active Active
- 2005-10-10 BR BRPI0516873-2A patent/BRPI0516873A/pt not_active Application Discontinuation
- 2005-10-11 AR ARP050104257A patent/AR051386A1/es not_active Application Discontinuation
- 2005-10-11 PE PE2005001202A patent/PE20060581A1/es not_active Application Discontinuation
- 2005-10-11 TW TW094135403A patent/TWI361192B/zh active
- 2005-10-11 MY MYPI20054764A patent/MY140880A/en unknown
-
2007
- 2007-03-29 IL IL182307A patent/IL182307A/en active IP Right Grant
- 2007-04-11 EC EC2007007384A patent/ECSP077384A/es unknown
- 2007-04-11 TN TNP2007000133A patent/TNSN07133A1/fr unknown
- 2007-04-12 MA MA29826A patent/MA28932B1/fr unknown
- 2007-04-24 NO NO20072127A patent/NO338603B1/no unknown
- 2007-10-05 HK HK07110850.1A patent/HK1105634A1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY30931A1 (es) | Amidas de 4-aril-1,4-dihidro-1,6-naftiridina sustituidas y su uso | |
| AR057239A1 (es) | Inmunoglobulinas | |
| DOP2007000053A (es) | Compuestos de tetrahidropiridotienopirimidina y métodos para su empleo | |
| HN2003000416A (es) | Derivados de pirrolopirimidina | |
| UY30578A1 (es) | Nuevos derivados de 2,4??- y 3, 4??-bipiridina sustituidos, procedimientos para su preparacion, medicamentos conteniéndolos y aplicaciones | |
| CR8649A (es) | Derivados de formamidina para el tratamiento de enfermedades | |
| PA8671301A1 (es) | Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricación y utilización | |
| TW200637614A (en) | Bendamustine pharmaceutical compositions | |
| UY33616A (es) | Compuestos con estructura de imidazotriazinona | |
| UY29636A1 (es) | 2,4-diamino-pirimidinas como inhibidores de aurora | |
| PA8766201A1 (es) | Metodos de fabricacion y uso de compuestos y composiciones | |
| UY32240A (es) | Nuevas 2,4-diaminopirimidinas, sus sales farmacéuticamente aceptables, composiciones conteniéndolas y aplicaciones. | |
| UY28724A1 (es) | Derivados de sulfonamida para el tratamiento de enfermedades | |
| DOP2006000087A (es) | Compuestos heteroaromaticos acilaminobiciclicos y sus usos | |
| UY29149A1 (es) | Tiazolil-dihidro-indazoles | |
| CR8636A (es) | Compuestos utiles para el tratamiento de enfermedades | |
| GT200300241A (es) | Benzoxazinonas sustituidas y usos de las mismas | |
| CR11273A (es) | Derivados-2-ona disustituidos en 3, su preparacion y su aplicacion en terapeutica | |
| UY29417A1 (es) | Agentes endoparasiticidas | |
| BR0314247A (pt) | Palatinose condensada na forma hidrogenada | |
| GT200500292A (es) | Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica | |
| GT200500282A (es) | Heteroatomos conteniendo compuestos triciclicos. | |
| AR060402A1 (es) | Compuestos organicos y sus usos | |
| UY28819A1 (es) | Derivados de formamida para el tratamiento de enfermedades | |
| GT200500059A (es) | Compuestos para el tratamiento de enfermedades |